Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohort
about
Comparative effectiveness research with administrative health data in rheumatoid arthritis.The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countriesImpact of an enhanced pharmacy discharge service on prescribing appropriateness criteria: a randomised controlled trial.Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching.
P2860
Prescriber preference for a particular tumour necrosis factor antagonist drug and treatment discontinuation: population-based cohort
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prescriber preference for a pa ...... ation: population-based cohort
@ast
Prescriber preference for a pa ...... ation: population-based cohort
@en
Prescriber preference for a pa ...... ation: population-based cohort
@nl
type
label
Prescriber preference for a pa ...... ation: population-based cohort
@ast
Prescriber preference for a pa ...... ation: population-based cohort
@en
Prescriber preference for a pa ...... ation: population-based cohort
@nl
prefLabel
Prescriber preference for a pa ...... ation: population-based cohort
@ast
Prescriber preference for a pa ...... ation: population-based cohort
@en
Prescriber preference for a pa ...... ation: population-based cohort
@nl
P2093
P2860
P1433
P1476
Prescriber preference for a pa ...... ation: population-based cohort
@en
P2093
Hugh J Freeman
James M Wright
Ken Bassett
M Alan Brookhart
P2860
P304
P356
10.1136/BMJOPEN-2014-005532
P577
2014-09-30T00:00:00Z